[1]
“Evaluation of Clinical Outcome of 6 months Anti-TB therapy in Rifampicin sensitive Tubercular Cervical Lymphadenopathy in Tertiary Level Hospital, Dhaka, Bangladesh”, Planet (Barisal), vol. 10, no. 01, pp. 15–21, Jul. 2026, doi: 10.5281/zenodo.21773667.